Concert Pharmaceuticals, Inc. (CNCE) Social Stream



Concert Pharmaceuticals, Inc. (CNCE): $8.37

0.01 (+0.12%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add CNCE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#216 of 400

in industry

CONCERT PHARMACEUTICALS INC (CNCE) Price Targets From Analysts

Use the tables below to see what analysts covering CONCERT PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 1 $22 $9 $14.25 $8.37 70.25%
2022-03-04 3 $22 $9 $14.375 $8.37 71.74%
2022-05-06 4 $22 $9 $14.375 $8.37 71.74%
2022-08-05 4 $22 $9 $15.5 $8.37 85.19%
2022-09-13 4 $25 $9 $16.25 $8.37 94.15%
2022-11-08 3 $25 $15 $19 $8.37 127%
2023-01-19 2 $17 $9 $11.666 $8.37 39.38%

The Trend in the Analyst Price Target


CNCE's average price target has moved down $3.66 over the prior 18 months.

CNCE reports an average of 203.35% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-22 4 22 9 14.375 3.10 363.71%
2022-09-13 3 25 14 18.666 6.99 167.04%
2022-11-08 3 25 15 19.000 4.46 326.01%
2023-01-19 2 17 9 11.666 8.29 40.72%
2023-01-19 3 17 9 11.666 8.29 40.72%

CNCE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 1 0 1 0 0 2

The Trend in the Broker Recommendations


Over the past 44 weeks, CNCE's average broker recommendation rating worsened by 0.67.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how CONCERT PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 194.9% of that group.
  • In terms of how CONCERT PHARMACEUTICALS INC fares relative to all US stocks, note that its average analyst price target is greater than 273.64% of that group.
  • To contextualize these metrics, consider that out of all US stocks, CONCERT PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1094.4% of them.
  • In the context of Pharmaceutical Products stocks, CONCERT PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 536.69% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CONCERT PHARMACEUTICALS INC are CARA, SESN, and TRVN.

Make investment decisions regarding CNCE using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!